Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma

PURPOSE: Neoadjuvant chemoradiation or chemotherapy has improved the treatment efficacy of patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma (PDAC). Due to the optimal regimen remains inconclusive, we aimed to compare these treatments in terms of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qiancheng, Wang, Dan, Chen, Ye, Li, Xiaofen, Cao, Peng, Cao, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617703/
https://www.ncbi.nlm.nih.gov/pubmed/31291998
http://dx.doi.org/10.1186/s13014-019-1330-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617703/
https://www.ncbi.nlm.nih.gov/pubmed/31291998
http://dx.doi.org/10.1186/s13014-019-1330-0

Ejemplares similares